+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pneumococcal Polysaccharide Vaccine"

H1N1 Vaccine Global Market Report 2024 - Product Thumbnail Image

H1N1 Vaccine Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
From
From
Global Pneumococcal Vaccine Market 2023-2027 - Product Thumbnail Image

Global Pneumococcal Vaccine Market 2023-2027

  • Report
  • September 2023
  • 155 Pages
  • Global
From
From
From
Disease Analysis: Pneumococcal Vaccines - Product Thumbnail Image

Disease Analysis: Pneumococcal Vaccines

  • Report
  • May 2021
  • 45 Pages
  • Global
Pneumovax 23 - Product Thumbnail Image

Pneumovax 23

  • Report
  • December 2018
  • 14 Pages
  • Global
From
From
From
From
Loading Indicator

The Pneumococcal Polysaccharide Vaccine (PPV) is a vaccine used to protect against infections caused by the bacterium Streptococcus pneumoniae. It is recommended for adults over the age of 65, as well as those with certain medical conditions, such as asthma, diabetes, and heart disease. The vaccine is administered as a single injection, and is usually given in combination with other vaccines. It is also recommended for children aged 2-5 years, and for those who are at high risk of developing pneumococcal disease. PPV is a widely used vaccine, and is available in many countries around the world. It is typically administered in combination with other vaccines, such as the influenza vaccine, and is often given in combination with other vaccines in a single injection. The PPV market is highly competitive, with many companies offering the vaccine. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more